Cargando…
Triple-negative breast cancer: A run-through of features, classification and current therapies
Breast cancer is the most prevalent cancer in women worldwide. Triple-negative breast cancer (TNBC) is characterized by the lack of expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. It is the most aggressive subtype of breast cancer and accounts fo...
Autores principales: | Manjunath, Meghana, Choudhary, Bibha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114477/ https://www.ncbi.nlm.nih.gov/pubmed/33986872 http://dx.doi.org/10.3892/ol.2021.12773 |
Ejemplares similares
-
SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end‐joining
por: Manjunath, Meghana, et al.
Publicado: (2021) -
Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016) -
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher, Brett, et al.
Publicado: (2016) -
Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer
por: Dias, Cristina J., et al.
Publicado: (2021) -
A review of current progress in triple-negative breast cancer therapy
por: Shen, Meiying, et al.
Publicado: (2020)